Physician profile
Francis J Devito
NPI 1508842519
$4,068.20
in general payments reported to CMS, 2019-2025
21 companies · $834 in 2025
The $834 reported for 2025 was more than what 97% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $710 · 2020: $322 · 2021: $592 · 2022: $465 · 2023: $774 · 2024: $371 · 2025: $834.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,978.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,978.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $1,617.62 | 2019-2025 | Bexsero, Penmenvy |
| Sanofi Pasteur INC. | $456.32 | 2019-2025 | |
| Pfizer INC. | $346.38 | 2020-2025 | |
| Merck Sharp & Dohme LLC | $333.40 | 2019-2025 | Vaxneuvance, Gardasil 9, Proquad |
| Regeneron Healthcare Solutions, INC. | $250.00 | 2021-2022 | |
| Ars Pharmaceuticals Operations, INC. | $182.93 | 2025 | Neffy |
| Sobi, INC | $133.41 | 2019-2021 | |
| Kaleo, INC. | $123.21 | 2021-2024 | Auvi-Q |
| Cranial Technologies, INC | $119.72 | 2019-2025 | Doc Band |
| Myriad Women'S Health, INC. | $96.77 | 2023 | Myrisk |
| Cumberland Pharmaceuticals, INC. | $84.72 | 2023-2024 | Kristalose |
| Sanofi-Aventis U.S. LLC | $78.10 | 2025 | |
| Phadia US INC. | $64.12 | 2019-2023 | Immunocap |
| Seqirus USA INC | $51.25 | 2023-2025 | Flucelvax, Flucelvax Quadrivalent |
| Alk-Abello, INC | $32.34 | 2025 | Neffy |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medline Industries Lp | $17.84 | 2019 | |
| Aimmune Therapeutics, INC. | $17.82 | 2023 | |
| Genzyme Corporation | $16.30 | 2023 | |
| Abbott Laboratories | $15.94 | 2025 | Id Now Instrument |
| Genentech USA, INC. | $15.71 | 2019 | |
| Otsuka America Pharmaceutical, INC. | $14.30 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Francis Devito listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.